Skip to Content
Get key facts and figures about chronic dry eye

Drug interactions between dextromethorphan / quinidine and Diamox

Results for the following 2 drugs:
Diamox (acetazolamide)

Interactions between your drugs


quiNIDine acetaZOLAMIDE

Applies to: dextromethorphan / quinidine and Diamox (acetazolamide)

AcetaZOLAMIDE may increase the blood levels and effects of quiNIDine in some people. Contact your doctor if you experience ringing in the ears, hearing loss, visual problems, diarrhea, headache, dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with these medications, as they may be symptoms of excessive effects of quiNIDine. You may need a dose adjustment or special tests to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions


quiNIDine food

Applies to: dextromethorphan / quinidine

Do not consume grapefruit or grapefruit juice during treatment with quiNIDine unless specifically directed otherwise by your doctor. Grapefruit and grapefruit juice can interact with quiNIDine and decrease the levels of quiNIDine in your body. If you are already consuming grapefruit products, do not increase or decrease the amount of these products in your diet without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No therapeutic duplications were found for your selected drugs.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.